Oxycodone and Sufentanil for Analgesia in Hip Surgery

• Status: Enrolling by invitation
• Trial end date: 2022-07-31
• Target enrollment: 0
• Participant gender: All

Summary

We design this randomized controlled trial to compare the safety and efficacy of Oxycodone and Sufentanil for postoperative patient-controlled analgesia in patients undergoing hip surgery, with a view to finding the optimal postoperative analgesic regime with fewer adverse reactions and promoting patients' rehabilitation.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: West China Hospital
• Treatments: Analgesics; Dsuvia; Oxycodone; Sufentanil

Criteria

Inclusion Criteria:

• Patients undergoing unilateral hip surgery, sign the "informed consent form"

• Age above 18 years old

Exclusion Criteria:

• Pregnant or lactating women

• Patients with history of drug abuse, including but not limited to opioids, amphetamines, ketamine, etc

• Allergic to opioids

• Have history of nervous system diseases such as peripheral neuropathy, or psychiatric mental illness

• Other conditions that the investigators consider unsuitable for participation in the study, such as deaf, Parkinson's disease, and difficult to communication etc